Alcidion accorded preferred provider status in the UK
Shares in Alcidion Group Ltd (ASX:ALC) traded nearly 10% higher on Tuesday morning after the company announced that it had been selected in the UK as the preferred provider for Dartford and Gravesham NHS Trust’s Electronic Prescription Medications Administration System.
Importantly, the award of preferred provider status resulted from a competitive tender process.
Upon final contract, Alcidion will deploy Better by Marand’s OPENeP platform, an electronic medication management system that is designed to prevent adverse medication related events.
In April 2019, Alcidion was appointed as a reseller partner by Better by Marand for the UK, Australia and New Zealand.
Alcidion managing director Kate Quirke noted that this was an endorsement of the group’s broader capabilities in saying, “We are delighted to extend our existing relationship with the Dartford and Gravesham NHS Trust.
Potential for further opportunities
‘’The selection of Alcidion demonstrates the breadth of our capabilities and our value as the Trust’s strategic partner to support its goal of being Paperless at the Point of Care by 2020.
“This is the first major tender for which Alcidion has been selected to supply the OPENeP platform.’’
The award of preferred provider status demonstrates the power of Alcidion’s expanded portfolio of complementary products and solutions that sit alongside Miya and Patientrack, enabling the group to offer a truly best-of-breed integrated solution that covers a wide range of clinical needs including next generation medications management.
This is subject to approval of the business case by the Trust Board and successful negotiation and final approval of a contract, which is expected in late 2019.
It should be noted that Alcidion does not normally announce the award of preferred provider status, however this information is considered material and likely to be shared beyond the Trust and Alcidion and hence has been released ahead of a final contract being signed.